Alarelin | CAS:79561-22-1

We serve Alarelin CAS:79561-22-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Alarelin

Chemical Name:Alarelin
CAS.NO:79561-22-1
Synonyms:Alarelin
Alareline Acetate
5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-alanyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide
5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-alanyl-L-leucyl-N5-(diaminomethylene)-L-ornithyl-N-ethyl-L-prolinamide
 
Physical and Chemical Properties:
Density 1.482 g/cm3
Molecular Formula C60H86N16O16
Molecular Weight 1287.42
Index of Refraction 1.694
 
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:For treatment of endmometriosis.



Contact us for information like Alarelin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-alanyl-L-leucyl-N5-(diaminomethylene)-L-ornithyl-N-ethyl-L-prolinamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-alanyl-L-leucyl-N5-(diaminomethylene)-L-ornithyl-N-ethyl-L-prolinamide Use and application,5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-alanyl-L-leucyl-N5-(diaminomethylene)-L-ornithyl-N-ethyl-L-prolinamide technical grade,usp/ep/jp grade.


Related News: If the drug is in a syrup form, then the excipient is the liquid that has been used to make it as such.4-chloro-1,3-benzothiazol-2-amine manufacturer The patient, who arrived from Wuhan, is “stable and under medical care,” the ministry said in a statement, adding there is “no cause for concern” for the public.2-Amino-5-nitropyridine supplier “Our priority is not only to protect and inform the residents of Boston but also to help this man continue to recover.3,4-Difluorotoluene vendor China has granted conditional approval to its first self-developed treatment for Alzheimer’s disease, a move that may point to revived opportunities in a therapeutic area where drugmakers have burned billions of dollars without yielding a validated new drug.The overall competition in China’s specialty drug substance market is relatively moderate, but due to the higher technical barriers and higher entry barriers for new entrants, there will be no obvious intensified competition in the short term.